Loading...
Header Logo
Keywords
Last Name
Institution

GUILIN TANG

TitleAssistant Professor
InstitutionMD Anderson
DepartmentHematopathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. J Mol Diagn. 2019 Mar; 21(2):343-351. PMID: 30576868.
      View in: PubMed
    2. Zou YH, Zhao L, Xu YK, Bao JM, Liu X, Zhang JS, Li W, Ahmed A, Yin S, Tang GH. Anti-inflammatory sesquiterpenoids from the Traditional Chinese Medicine Salvia plebeia: Regulates pro-inflammatory mediators through inhibition of NF-?B and Erk1/2 signaling pathways in LPS-induced Raw264.7 cells. J Ethnopharmacol. 2018 Jan 10; 210:95-106. PMID: 28847754.
      View in: PubMed
    3. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica. 2017 09; 102(9):1511-1518. PMID: 28473622.
      View in: PubMed
    4. Li S, Weiss VL, Wang XJ, Desai PA, Hu S, Yin CC, Tang G, Reddy NM, Medeiros LJ, Lin P. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol. 2016 Feb; 40(2):253-61. PMID: 26448193.
      View in: PubMed
    5. Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang SA. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. Am J Hematol. 2015 Oct; 90(10):882-7. PMID: 26148174.
      View in: PubMed
    6. Tang GH, Chen ZW, Lin TT, Tan M, Gao XY, Bao JM, Cheng ZB, Sun ZH, Huang G, Yin S. Neolignans from Aristolochia fordiana Prevent Oxidative Stress-Induced Neuronal Death through Maintaining the Nrf2/HO-1 Pathway in HT22 Cells. J Nat Prod. 2015 Aug 28; 78(8):1894-903. PMID: 26226070.
      View in: PubMed
    7. Tang G, Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, DiNardo C, Medeiros LJ. Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant. Am J Clin Pathol. 2015 Jul; 144(1):78-86. PMID: 26071464.
      View in: PubMed
    8. Chen Z, Wang W, Rich A, Tang G, Hu S. Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases. Am J Hematol. 2015 Aug; 90(8):E146-8. PMID: 25960187.
      View in: PubMed
    9. Liu H, Wang W, Tang G, Yin CC, Muzzafar T, Medeiros LJ, Hu S. Lymphomatous variant of hairy cell leukaemia: a distinctive presentation mimicking low-grade B-cell lymphoma. Histopathology. 2015 Nov; 67(5):740-5. PMID: 25809821.
      View in: PubMed
    10. Ouyang J, Goswami M, Tang G, Peng J, Ravandi F, Daver N, Routbort M, Konoplev S, Lin P, Medeiros LJ, Jorgensen JL, Wang SA. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia. Am J Hematol. 2015 Jun; 90(6):504-10. PMID: 25732229.
      View in: PubMed
    11. Cheng ZB, Lu X, Bao JM, Han QH, Dong Z, Tang GH, Gan LS, Luo HB, Yin S. (±)-Torreyunlignans A-D, rare 8-9' linked neolignan enantiomers as phosphodiesterase-9A inhibitors from Torreya yunnanensis. J Nat Prod. 2014 Dec 26; 77(12):2651-7. PMID: 25495612.
      View in: PubMed
    12. Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, Goswami M, Yin CC, Lu G, Medeiros LJ, Tang G. Isolated +15 in bone marrow: disease-associated or a benign finding? Leuk Res. 2015 Jan; 39(1):72-6. PMID: 25435027.
      View in: PubMed
    13. Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, Muzzafar T, Medeiros LJ, Wang SA, Bueso-Ramos CE. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol. 2015 Jan; 46(1):65-73. PMID: 25387813.
      View in: PubMed
    14. Wang YH, Goto M, Wang LT, Hsieh KY, Morris-Natschke SL, Tang GH, Long CL, Lee KH. Multidrug resistance-selective antiproliferative activity of Piper amide alkaloids and synthetic analogues. Bioorg Med Chem Lett. 2014 Oct 15; 24(20):4818-21. PMID: 25241925.
      View in: PubMed
    15. DiNardo CD, Tang G, Pemmaraju N, Wang SA, Pike A, Garcia-Manero G, Cortes J, Bueso-Ramos C, Kantarjian HM. Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation. Clin Lymphoma Myeloma Leuk. 2015 Jan; 15(1):47-51. PMID: 25081372.
      View in: PubMed
    16. Wang XY, Yuan CM, Tang GH, Zou T, Guo F, Liao JH, Zhang HY, Zuo GY, Rao GX, Zhao Q, Hao XJ, He HP. Limonoids from the fruits of Cipadessa cinerascens. J Asian Nat Prod Res. 2014; 16(7):795-9. PMID: 24915831.
      View in: PubMed
    17. Tang G, Wang SA, Lu V, Lee HC, Qazilbash MH, Wang XI, Yin CC, Orlowski R, Wang Y, Patel A, Medeiros LJ, Lu G. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leuk Res. 2014 Aug; 38(8):896-900. PMID: 24939217.
      View in: PubMed
    18. Tang G, Zhang L, Fu B, Hu J, Lu X, Hu S, Patel A, Goswami M, Khoury JD, Garcia-Manero G, Medeiros LJ, Wang SA. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution. Am J Hematol. 2014 Aug; 89(8):813-8. PMID: 24782398.
      View in: PubMed
    19. Tang G, Lu X, Wang SA, Roney EK, Zhang L, Hu S, Lu G, Medeiros LJ, Patel A. Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms. Int J Clin Exp Pathol. 2014; 7(6):3196-201. PMID: 25031740.
      View in: PubMed
    20. Lin TT, Huang YY, Tang GH, Cheng ZB, Liu X, Luo HB, Yin S. Prenylated coumarins: natural phosphodiesterase-4 inhibitors from Toddalia asiatica. J Nat Prod. 2014 Apr 25; 77(4):955-62. PMID: 24597921.
      View in: PubMed
    21. Cheng YY, Chen H, He HP, Zhang Y, Li SF, Tang GH, Guo LL, Yang W, Zhu F, Zheng YT, Li SL, Hao XJ. Anti-HIV active daphnane diterpenoids from Trigonostemon thyrsoideum. Phytochemistry. 2013 Dec; 96:360-9. PMID: 24210372.
      View in: PubMed
    22. Yuan CM, Tang GH, Wang XY, Zhang Y, Cao MM, Li XH, Li Y, Li SL, Di YT, He HP, Hao XJ, Hua HM. New steroids and sesquiterpene from Turraea pubescens. Fitoterapia. 2013 Oct; 90:119-25. PMID: 23856090.
      View in: PubMed
    23. Huang SD, Zhang Y, He HP, Li SF, Tang GH, Chen DZ, Cao MM, DI YT, Hao XJ. A new Amaryllidaceae alkaloid from the bulbs of Lycoris radiata. Chin J Nat Med. 2013 Jul; 11(4):406-10. PMID: 23845551.
      View in: PubMed
    24. Yuan CM, Tang GH, Zhang Y, Wang XY, Cao MM, Guo F, Li Y, Di YT, Li SL, Hua HM, He HP, Hao XJ. Bioactive limonoid and triterpenoid constituents of Turraea pubescens. J Nat Prod. 2013 Jun 28; 76(6):1166-74. PMID: 23734701.
      View in: PubMed
    25. Yuan CM, Tang GH, Wang XY, Zhang Y, Guo F, Liao JH, Zou T, Zuo GY, Hua HM, He HP, Hao XJ. Two new compounds from Khaya senegalensis. J Asian Nat Prod Res. 2013; 15(6):638-43. PMID: 23662596.
      View in: PubMed
    26. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PM, Huh YO, Jones DM, Bueso-Ramos C, Verstovsek S, Medeiros LJ, Miranda RN. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol. 2013 Mar; 88(3):219-24. PMID: 23440662.
      View in: PubMed
    27. Huang SD, Zhang Y, Cao MM, Di YT, Tang GH, Peng ZG, Jiang JD, He HP, Hao XJ. Myriberine A, a new alkaloid with an unprecedented heteropentacyclic skeleton from Myrioneuron faberi. Org Lett. 2013 Feb 01; 15(3):590-3. PMID: 23320525.
      View in: PubMed
    28. Ma LJ, Wang YH, Tang GH, Wang YL, Ma C, Dastmalchi K, Kennelly EJ, Long CL. New monoterpene lactones from Actaea cimicifuga. Planta Med. 2013 Mar; 79(3-4):308-11. PMID: 23322559.
      View in: PubMed
    29. Wang XY, Tang GH, Yuan CM, Zhang Y, Zou T, Yu C, Zhao Q, Hao XJ, He HP. Aphagrandinoids A-D, cycloartane triterpenoids with antibacterial activities from Aphanamixis grandifolia. Fitoterapia. 2013 Mar; 85:64-8. PMID: 23313271.
      View in: PubMed
    30. Yuan CM, Zhang Y, Tang GH, Di YT, Cao MM, Wang XY, Zuo GY, Li SL, Hua HM, He HP, Hao XJ. Khayseneganins A-H, limonoids from Khaya senegalensis. J Nat Prod. 2013 Mar 22; 76(3):327-33. PMID: 23210623.
      View in: PubMed
    31. Tang GH, Zhang Y, Yuan CM, Li Y, Gu YC, Di YT, Wang YH, Zuo GY, Li SF, Li SL, He HP, Hao XJ. Trigohowilols A-G, degraded diterpenoids from the stems of Trigonostemon howii. J Nat Prod. 2012 Nov 26; 75(11):1962-6. PMID: 23148674.
      View in: PubMed
    32. Tang G, Banks HE, Sargent RL, Medeiros LJ, Abruzzo LV. Chronic lymphocytic leukemia with t(14;18)(q32;q21). Hum Pathol. 2013 Apr; 44(4):598-605. PMID: 23084581.
      View in: PubMed
    33. Yuan CM, Zhang Y, Tang GH, Li SL, Di YT, Hou L, Cai JY, Hua HM, He HP, Hao XJ. Senegalensions A-C, three limonoids from Khaya senegalensis. Chem Asian J. 2012 Sep; 7(9):2024-7. PMID: 22733621.
      View in: PubMed
    34. Liu D, Lin P, Hu Y, Zhou Y, Tang G, Powers L, Medeiros LJ, Jorgensen JL, Wang SA. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma. J Clin Pathol. 2012 Sep; 65(9):823-9. PMID: 22685235.
      View in: PubMed
    35. Tang G, Jorgensen LJ, Zhou Y, Hu Y, Kersh M, Garcia-Manero G, Medeiros LJ, Wang SA. Multi-color CD34? progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia. Leuk Res. 2012 Aug; 36(8):974-81. PMID: 22626984.
      View in: PubMed
    36. Cheng YY, Li SF, Zhang Y, Tang GH, Di YT, Hao XJ, Li SL, He HP. Cleidbrevoids A-C, new clerodane diterpenoids from Cleidion brevipetiolatum. Fitoterapia. 2012 Sep; 83(6):1100-4. PMID: 22580163.
      View in: PubMed
    37. Tang GH, Zhang Y, Gu YC, Li SF, Di YT, Wang YH, Yang CX, Zuo GY, Li SL, He HP, Hao XJ. Trigoflavidols A-C, degraded diterpenoids with antimicrobial activity, from Trigonostemon flavidus. J Nat Prod. 2012 May 25; 75(5):996-1000. PMID: 22548480.
      View in: PubMed
    38. Cai JY, Zhang Y, Luo SH, Chen DZ, Tang GH, Yuan CM, Di YT, Li SH, Hao XJ, He HP. Aphanamixoid A, a potent defensive limonoid, with a new carbon skeleton from Aphanamixis polystachya. Org Lett. 2012 May 18; 14(10):2524-7. PMID: 22540189.
      View in: PubMed
    39. Tang G, Zuo Z, Thomas DA, Lin P, Liu D, Hu Y, Kantarjian HM, Bueso-Ramos C, Medeiros LJ, Wang SA. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related? Haematologica. 2012 Jun; 97(6):919-25. PMID: 22207681.
      View in: PubMed
    40. Zhou Y, Tang G, Medeiros LJ, McDonnell TJ, Keating MJ, Wierda WG, Wang SA. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Mod Pathol. 2012 Feb; 25(2):237-45. PMID: 22080061.
      View in: PubMed
    41. Wang HS, Sun L, Wang YH, Shi YN, Tang GH, Zhao FW, Niu HM, Long CL, Li L. Carboxymethyl flavonoids and a monoterpene glucoside from Selaginella moellendorffii. Arch Pharm Res. 2011 Aug; 34(8):1283-8. PMID: 21910049.
      View in: PubMed
    42. Huang QQ, Bi JL, Sun QY, Yang FM, Wang YH, Tang GH, Zhao FW, Wang H, Xu JJ, Kennelly EJ, Long CL, Yin GF. Bioactive isoquinoline alkaloids from Corydalis saxicola. Planta Med. 2012 Jan; 78(1):65-70. PMID: 21858757.
      View in: PubMed
    43. Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leuk Res. 2011 Jun; 35(6):766-70. PMID: 21367453.
      View in: PubMed
    44. Tang GH, Chen DM, Qiu BY, Sheng L, Wang YH, Hu GW, Zhao FW, Ma LJ, Wang H, Huang QQ, Xu JJ, Long CL, Li J. Cytotoxic amide alkaloids from Piper boehmeriaefolium. J Nat Prod. 2011 Jan 28; 74(1):45-9. PMID: 21158422.
      View in: PubMed
    45. Zhao FW, Luo M, Wang YH, Li ML, Tang GH, Long CL. A piperidine alkaloid and limonoids from Arisaema decipiens, a traditional antitumor herb used by the Dong people. Arch Pharm Res. 2010 Nov; 33(11):1735-9. PMID: 21116775.
      View in: PubMed
    46. Zhao FW, Sun QY, Yang FM, Hu GW, Luo JF, Tang GH, Wang YH, Long CL. Palhinine A, a novel alkaloid from Palhinhaea cernua. Org Lett. 2010 Sep 03; 12(17):3922-5. PMID: 20690613.
      View in: PubMed
    47. Niu HM, Zeng DQ, Long CL, Peng YH, Wang YH, Luo JF, Wang HS, Shi YN, Tang GH, Zhao FW. Clerodane diterpenoids and prenylated flavonoids from Dodonaea viscosa. J Asian Nat Prod Res. 2010 Jan; 12(1):7-14. PMID: 20390737.
      View in: PubMed
    48. Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang SA. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood. 2010 Mar 11; 115(10):1985-92. PMID: 20040759.
      View in: PubMed
    49. Tang GH, Sun CS, Long CL, Li ML, Wang YH, Luo M, Wang HS, Shi YN. Sesquiterpenoids from Pilea cavaleriei subsp. crenata. Bioorg Med Chem Lett. 2009 Oct 01; 19(19):5737-40. PMID: 19700322.
      View in: PubMed
    50. Wang YH, Long CL, Yang FM, Wang X, Sun QY, Wang HS, Shi YN, Tang GH. Pyrrolidinoindoline alkaloids from Selaginella moellendorfii. J Nat Prod. 2009 Jun; 72(6):1151-4. PMID: 19422203.
      View in: PubMed
    51. Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol. 2009 Aug; 40(8):1194-9. PMID: 19427022.
      View in: PubMed
    52. Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer. 2008 Dec 15; 113(12):3331-40. PMID: 18988232.
      View in: PubMed
    53. Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol. 2008 Nov; 21(11):1394-402. PMID: 18839018.
      View in: PubMed
    54. Tang F, Tang G, Xiang J, Dai Q, Rosner MR, Lin A. The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2002 Dec; 22(24):8571-9. PMID: 12446776.
      View in: PubMed
    55. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature. 2001 Nov 15; 414(6861):313-7. PMID: 11713531.
      View in: PubMed
    56. Tang G, Yang J, Minemoto Y, Lin A. Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell. 2001 Nov; 8(5):1005-16. PMID: 11741536.
      View in: PubMed
    57. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A. 2001 Jun 05; 98(12):6668-73. PMID: 11381115.
      View in: PubMed
    58. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated with Poor Prognosis. Pediatric Hematology and Oncology. 32:535-547.
    59. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response. European Journal of Haematology. 95:168-176.
    60. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not MLL gene. Journal of Clinical Pathology.
    61. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. Journal of Hematology and Oncology. 8.
    62. Cytogenetic evolution associated with disease progression in Hematopoietic neoplasms with t(8;22)(p11;q11)/BCR-FQFR1 rearrangement. JNCCN Journal of the National Comprehensive Cancer Network. 14:708-711.
    63. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Modern Pathology.
    64. Simultaneous deletion of 3'ETV6 and 5' EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm. Molecular Cytogenetics. 9.
    65. Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation. European Journal of Haematology.
    66. MYC/BCL6 double-hit lymphoma (DHL). Histopathology.
    67. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia. American Journal of Surgical Pathology.
    68. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia. Journal of Hematology and Oncology. 8.
    69. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease. American Journal of Hematology.
    70. Tetraploidy/near-tetraploidy acute myeloid leukemia. Leukemia Research. 53:20-27.
    71. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood. 127:2742-2750.
    72. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients. Journal of Hematology and Oncology. 8.
    73. Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia.
    74. Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Annals of Hematology. 1-4.
    75. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Modern Pathology.
    76. Human Pathology. 60:160-166.
    77. Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. American Journal of Hematology.
    78. The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Modern Pathology.
    79. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype. Cancer genetics. 209:313-320.
    80. Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms. Modern Pathology.
    81. Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms. Molecular Cytogenetics. 9.
    82. Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression. Molecular Cytogenetics. 8.
    83. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget. 7:38122-38132.
    84. Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival. Clinical Lymphoma, Myeloma and Leukemia. 15:556-562.
    85. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment. Leukemia.
    86. Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations. American Journal of Hematology. 91:354-355.
    87. Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs). Leukemia and Lymphoma. 57:812-819.
    88. Del(20q) in patients with chronic lymphocytic leukemia. Modern Pathology. 28:1130-1137.
    89. Clinical significance of acquired loss of the X chromosome in bone marrow. Leukemia Research. 47:109-113.
    90. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features. Clinical Lymphoma, Myeloma and Leukemia. 15:S85-S90.
    91. Advances in B-lymphoblastic leukemia. Annals of Diagnostic Pathology.
    TANG's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description